Skip to main navigation

Investor Relations

Home
News & Events
News Releases Events and Presentations
Stock
Stock Quote & Chart Analyst Coverage
Corporate Governance
Documents & Charters Management Board of Directors Committee Composition
Financial Information
SEC Filings
Resources
Investor FAQs Email Alerts Document Request

News Releases

Year

Feb 01, 2023

Candel Therapeutics to Participate in Guggenheim Healthcare Talks 2023 Oncology Day

NEEDHAM, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced that Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer, will participate in a fireside

Additional Formats

Jan 12, 2023

Candel Therapeutics to Participate in Upcoming B. Riley Oncology Conference

NEEDHAM, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company developing novel viral immunotherapies, today announced that Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer, will participate in a virtual

Additional Formats

Shareholder Tools

Print Page
Email Alerts
RSS
FAQ

© Candel Therapeutics, Inc 2023